期刊文献+

健脾养正消癥方对裸鼠皮下移植瘤中肿瘤转移相关因子的影响 被引量:7

Effects of Jianpi Yangzheng Xiaozheng Formula on the subcutaneous transplantation tumor in nude mice and its molecular mechanism of metastasis related factors
原文传递
导出
摘要 目的:观察健脾养正消癥方对BALB/c裸鼠人胃癌MGC-803细胞皮下移植瘤生长及转移的影响,并探讨其相关机制。方法:建立人胃癌MGC-803裸鼠皮下移植瘤模型,并随机分为阴性对照组、阳性对照组、健脾养正消癥方大、小剂量组,观察对裸鼠皮下移植瘤的抑制作用。使用荧光定量PCR检测移植瘤内RECK、c-myc、MMP-9、MMP-14、CXCR4和VEGFA的基因表达。Western blot检测移植瘤内的MMP-9、MMP-14、RECK、STAT3和p-STAT3的蛋白表达。结果:与阴性对照组比较,健脾养正消癥方大、小剂量组有明显缩小皮下移植瘤体积的作用。荧光定量PCR显示,健脾养正消癥方大剂量组中RECK的表达显著上调,而c-myc、MMP-9、MMP-14、CXCR4和VEGFA的表达均显著下调。Western blot检测显示,健脾养正消癥方大、小剂量组能上调RECK蛋白的表达,下调MMP-9、MMP-14的表达,并抑制p-STAT3表达。结论:健脾养正消癥方对胃癌MGC-803细胞裸鼠皮下移植瘤的生长有显著的抑制作用,其作用机制可能与该方调节胃癌组织中侵袭转移的相关基因、蛋白有关。 Objective: To observe the inhibitory rate of Jianpi Yangzheng Xiaozheng formla (JPYZXZ) on the transplanted tumor due to Gastric Cell Line MGC-803 in nude mice and to explore its molecular mechanism. Methods: Transplanted transplantation tumor nude model mice were made, and modeling nude mice were randomly divided into negative control group, positive control group and JPYZXZ formula group (high dose group, low dose group). The inhibitory rate of JPYZXZ formula on transplanted tumor was observed. Real-time PCR was used to detect the expression of RECK, C-MYC, MMP-9, MMP-14, CXCR4 and VEGFA from transplanted tumor. Western blot was used to detect the expression of MMP-9, MMP-14, RECK, stat3 and p-stat3. Results: The JPYZXZ formula high, low dose groups can inhibit the growth of transplanted tumor, with stastistic significant compared with negative control group. Comparing with the negative control group, gene expression of RECK upregulated and C-MYC, MMP-9, MMP-14, CXCR4, VEGFA downregulated in JPYZXZ formula group. Comparing with the negative control group, protein expression of RECK upregulated and MMP-9, MMP-14, p-stat3 in JPYZXZ formula group downregulated. Conclusion: JPYZXZ formula has significant inhibition effect on the transplanted transplantation tumor. Its mechanism may be related to invasion and metastasis related gene and protein in gastric cancer tissues.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2015年第9期3311-3314,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家中医药管理局项目(No.JDZX2012086) 国家自然科学基金面上项目(No.81473605) 江苏省临床医学科技专项(No.BL2014100) 江苏高校优势学科建设工程项目~~
关键词 健脾养正消癥方 胃癌MGC-803细胞 皮下移植瘤 作用机制 Jianpi Yangzheng Xiaozheng Formula Gastric cell line MGC-803 Transplantation tumor Molecular mechanism
  • 相关文献

参考文献5

二级参考文献30

  • 1Tsutomu Namikawa,Kazuhiro Hanazaki.Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma[J].World Journal of Gastroenterology,2010,16(37):4634-4639. 被引量:2
  • 2黎剑,蔡世荣,何裕隆,黄美近,董文广,梅开勇,汪建平,詹文华.淋巴结转移阴性的胃癌患者临床病理特征及生存分析[J].中华胃肠外科杂志,2006,9(3):230-233. 被引量:4
  • 3Malcolm G Smith,Georgina L Hold,Eiichi Tahara,Emad M El-Omar.Cellular and molecular aspects of gastric cancer[J].World Journal of Gastroenterology,2006,12(19):2979-2990. 被引量:29
  • 4Xiao-Feng Yang.Immunology of Stem Cells and Cancer Stem Cells[J].Cellular & Molecular Immunology,2007,4(3):161-171. 被引量:7
  • 5Bruno L, Nesi G, Montinaro F, et al. Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol, 2000,74( 1 ) : 30-32.
  • 6Baiocchi GL, Tiberio GA, Minicozzi AM, et al. A multicentric western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg, 2010,252( 1 ) :70-73.
  • 7Saito H, Kuroda H, Matsunaga T, et al. Prognostic indicators in nodenegative advanced gastric cancer patients. J Surg Oncol, 2010,101 (7) :622-625.
  • 8Park SS, Park JM, Kim JH, et al. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit? J Surg Oncol, 2006, 94( 1 ) : 16-20.
  • 9Kooby DA, Suriawinata A, Klimstra DS, et al. Biologic predictors of survival in node-negative gastric cancer. Ann Surg, 2003,237(6) : 828-837.
  • 10Kulig J, Popiela T, Kolodziejezyk P, et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric eaneer: an interim safety analysis of a multicenter, randomized, clinical trial. Ann J Surg, 2007,193(1) : 10-15.

共引文献100

同被引文献105

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部